Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.

Gesine van MarkStefanie LanzingerStefan SziegoleitFranz Josef PutzMesut DurmazMichaela BorschellerThomas DanneJochen SeufertReinhard W HollPeter Bramlage

Published in: Advances in therapy (2019)

German Centre for Diabetes Research (DZD) (01GI1106), the European Foundation for the Study of Diabetes (EFSD) and the German Diabetes Society (DDG). The DIVE registry (organized as Diabetes Agenda 2010 GmbH, Berlin, Germany) received funding from Sanofi, AstraZeneca, Bayer, and Abbott and was conducted under the auspices of diabetesDE.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
insulin resistance
weight loss
metabolic syndrome
global health